Scientist-Turned-Entrepreneur on a Mission to Transform Brain Imaging
Deep-tech entrepreneur and scientist dedicated to revolutionizing brain imaging. Founder of AiimSense, a medtech startup developing portable, AI-driven brain scanners for stroke and traumatic brain injuries. Over 10 years of experience in life sciences, imaging, and commercialization. Passionate about bridging the gap between cutting-edge research and real-world healthcare impact.
Innovation & Impact
Developed the first-of-its-kind portable brain scanner, leveraging electromagnetic tomography & AI
Secured funding from top health tech accelerators and government grants
Recognized as a leading health tech innovator (Inventures, UHN Aging Innovation, OBIO)
Collaborating with leading hospitals, stroke researchers, and emergency medical teams
What’s Next?
AiimSense is transitioning from preclinical validation to first-in-human studies, while building strategic partnerships to scale clinical adoption. I am actively engaging with investors, healthcare leaders, and industry experts to bring our cutting-edge neuroimaging technology to market.
Let’s connect if you’re interested in medtech, AI in healthcare, neuroimaging, or early-stage health innovation!
Scientist-Turned-Entrepreneur on a Mission to Transform Brain Imaging
Deep-tech entrepreneur and scientist dedicated to revolutionizing brain imaging. Founder of AiimSense, a medtech startup developing portable, AI-driven brain scanners for stroke and traumatic brain injuries. Over 10 years of experience in life sciences, imaging, and commercialization. Passionate about bridging the gap between cutting-edge research and real-world healthcare impact.
Innovation & Impact
Developed the first-of-its-kind portable brain scanner, leveraging electromagnetic tomography & AI
Secured funding from top health tech accelerators and government grants
Recognized as a leading health tech innovator (Inventures, UHN Aging Innovation, OBIO)
Collaborating with leading hospitals, stroke researchers, and emergency medical teams
What’s Next?
AiimSense is transitioning from preclinical validation to first-in-human studies, while building strategic partnerships to scale clinical adoption. I am actively engaging with investors, healthcare leaders, and industry experts to bring our cutting-edge neuroimaging technology to market.
Let’s connect if you’re interested in medtech, AI in healthcare, neuroimaging, or early-stage health innovation!
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy